Interim Results for the six months ended 31 December 2022
The Interim Results for the six months ended 31 December 2022 were announced on 19 June 2023
Welcome to the Allergy Therapeutics Investor Relations Centre.
Annual Report 2022
The Interim Results for the six months ended 31 December 2022 were announced on 19 June 2023